{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:49:38Z","timestamp":1783648178115,"version":"3.55.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670785"],"award-info":[{"award-number":["81670785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800701"],"award-info":[{"award-number":["81800701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870567"],"award-info":[{"award-number":["81870567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800731"],"award-info":[{"award-number":["81800731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970720"],"award-info":[{"award-number":["81970720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission","award":["2018QNXM001"],"award-info":[{"award-number":["2018QNXM001"]}]},{"name":"Chongqing Outstanding Youth Funds","award":["cstc2019jcyjjq0006"],"award-info":[{"award-number":["cstc2019jcyjjq0006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The Endocrine Society Guidelines for the diagnosis of primary aldosteronism (PA) suggest that confirmatory tests (CFT) are not required when the following criteria are met: plasma aldosterone concentration (PAC) is &amp;gt;20 ng\/dL, plasma renin is below detection levels, and hypokalemia is present. The evidence for the applicability of the guideline criteria is limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To develop and validate optimized criteria for sparing CFT in the diagnosis of PA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Setting<\/jats:title>\n                  <jats:p>The optimized criteria were developed in a Chinese cohort using the captopril challenge test, verified by saline infusion test (SIT) and fludrocortisone suppression test (FST), and validated in an Australian cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Hypertensive patients who completed PA screening and CFT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Diagnostic value of the optimized criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the development cohort (518 PA and 266 non-PA), hypokalemia, PAC, and plasma renin concentration (PRC) were selected as diagnostic indicators by multivariate logistic analyses. The combination of PAC &amp;gt;20 ng\/dL plus PRC &amp;lt;2.5 \u03bcIU\/mL plus hypokalemia had much higher sensitivity than the guideline criteria (0.36 vs 0.11). The optimized criteria remained superior when the SIT or FST were used as CFT. Non-PA patients were not misdiagnosed by either criteria, but the percentage of patients in whom CFT could be spared was higher with the optimized criteria. In the validation cohort (125 PA and 81 non-PA), the sensitivity of the optimized criteria was also significantly higher (0.12 vs 0.02).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Hypertensive patients with PAC\u2005&amp;gt;20 ng\/dL, PRC\u2005&amp;lt;2.5 \u03bcIU\/mL, plus hypokalemia can be confidently diagnosed with PA without confirmatory tests.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa282","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T16:19:50Z","timestamp":1590423590000},"page":"e2449-e2456","source":"Crossref","is-referenced-by-count":43,"title":["Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism"],"prefix":"10.1210","volume":"105","author":[{"given":"Kanran","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-4976","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia"},{"name":"Department of Medicine, Monash University, Clayton, Victoria, 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia"},{"name":"Department of Medicine, Monash University, Clayton, Victoria, 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hashimura","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7249-6445","authenticated-orcid":false,"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"issue":"11","key":"2021122116320660600_CIT0001","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol."},{"issue":"14","key":"2021122116320660600_CIT0002","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"7","key":"2021122116320660600_CIT0003","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122116320660600_CIT0004","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/EJE-14-0537","article-title":"Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension","volume":"172","author":"Piaditis","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021122116320660600_CIT0005","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122116320660600_CIT0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ando.2016.01.007","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing","volume":"77","author":"Reznik","year":"2016","journal-title":"Ann Endocrinol (Paris)."},{"issue":"9","key":"2021122116320660600_CIT0007","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J."},{"issue":"3","key":"2021122116320660600_CIT0008","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ando.2016.02.003","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 2: first diagnostic steps","volume":"77","author":"Douillard","year":"2016","journal-title":"Ann Endocrinol (Paris)."},{"issue":"3","key":"2021122116320660600_CIT0009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/a-0857-1620","article-title":"Evaluation of biochemical conditions allowing bypass of confirmatory testing in the workup of primary aldosteronism: a retrospective study in a French hypertensive population","volume":"51","author":"Vivien","year":"2019","journal-title":"Horm Metab Res."},{"issue":"4","key":"2021122116320660600_CIT0010","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz148","article-title":"Role of aldosterone and potassium levels in sparing confirmatory tests in primary aldosteronism","volume":"105","author":"Umakoshi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021122116320660600_CIT0011","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension."},{"key":"2021122116320660600_CIT0012","doi-asserted-by":"crossref","first-page":"8647026","DOI":"10.1155\/2018\/8647026","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol."},{"issue":"2","key":"2021122116320660600_CIT0013","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cen.14134","article-title":"A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism","volume":"92","author":"Lin","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"2021122116320660600_CIT0014","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41371-018-0069-7","article-title":"Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio","volume":"32","author":"Shu","year":"2018","journal-title":"J Hum Hypertens."},{"issue":"9","key":"2021122116320660600_CIT0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2021122116320660600_CIT0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension."},{"issue":"4","key":"2021122116320660600_CIT0017","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2021122116320660600_CIT0018","article-title":"Data from: supplements of development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism","author":"Wang","year":"2020","journal-title":"Figshare"},{"issue":"8","key":"2021122116320660600_CIT0019","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/HJH.0000000000001384","article-title":"Diagnostic rate of primary aldosteronism in Emilia-Romagna, Northern Italy, during 16 years (2000-2015)","volume":"35","author":"Rossi","year":"2017","journal-title":"J Hypertens."},{"issue":"11","key":"2021122116320660600_CIT0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41371-018-0094-6","article-title":"Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey","volume":"32","author":"Pucci","year":"2018","journal-title":"J Hum Hypertens."},{"key":"2021122116320660600_CIT0021","first-page":"115","article-title":"Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism","volume":"4","author":"Corbin","year":"2011","journal-title":"Int J Nephrol Renovasc Dis."},{"issue":"1","key":"2021122116320660600_CIT0022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","article-title":"Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension."},{"issue":"7","key":"2021122116320660600_CIT0023","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2007-973061","article-title":"The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system","volume":"115","author":"Diederich","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"2021122116320660600_CIT0024","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinbiochem.2018.04.016","article-title":"Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays","volume":"56","author":"Deng","year":"2018","journal-title":"Clin Biochem."},{"issue":"3","key":"2021122116320660600_CIT0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/HJH.0000000000000076","article-title":"Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension","volume":"32","author":"Lonati","year":"2014","journal-title":"J Hypertens."},{"issue":"6","key":"2021122116320660600_CIT0026","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0b013e32833857ad","article-title":"A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin","volume":"28","author":"Morganti","year":"2010","journal-title":"J Hypertens."},{"issue":"Pt 3","key":"2021122116320660600_CIT0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/acb.2010.009230","article-title":"A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin","volume":"47","author":"Dorrian","year":"2010","journal-title":"Ann Clin Biochem."},{"issue":"5","key":"2021122116320660600_CIT0028","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem."},{"issue":"9","key":"2021122116320660600_CIT0029","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","article-title":"Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays","volume":"50","author":"Perschel","year":"2004","journal-title":"Clin Chem."},{"issue":"3","key":"2021122116320660600_CIT0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122116320660600_CIT0031","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa117","article-title":"Baseline plasma aldosterone level and renin activity allowing omission of confirmatory testing in primary aldosteronism","volume":"105","author":"Kawashima","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021122116320660600_CIT0032","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension."},{"issue":"12","key":"2021122116320660600_CIT0033","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/s41440-019-0310-y","article-title":"Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling","volume":"42","author":"Aono","year":"2019","journal-title":"Hypertens Res."},{"issue":"6","key":"2021122116320660600_CIT0034","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization","volume":"105","author":"Rossitto","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa282\/33293699\/dgaa282.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/e2449\/41840902\/jcem_105_7_e2449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/e2449\/41840902\/jcem_105_7_e2449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T17:06:04Z","timestamp":1640106364000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/7\/e2449\/5843809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,5,25]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa282","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,5,25]]}}}